Jieting Gao, Kejun Wang, Ling Sang*
Department of Radiology, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China.
*Corresponding author: Ling Sang
Abstract
Objective: To analyze the efficacy of cardiac CT imaging (CCT) and cardiac magnetic resonance (CMR) in diagnosing diabetic cardiomyopathy. Methods: Eighty patients suspected of having diabetic cardiomyopathy admitted between January 2024 and June 2025 were enrolled. All underwent CCT and CMR examinations, with coronary angiography (CAG) serving as the gold standard. The diagnostic efficacy of CCT and CMR was compared. Results: Among 80 patients, CAG confirmed 66 positive and 14 negative cases; CCT identified 62 positives and 18 negatives; CMR identified 66 positives and 14 negatives. The accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of CMR were all higher than those of CCT (P < 0.05). Conclusion: Compared with CCT, CMR demonstrates higher accuracy, sensitivity, specificity, positive predictive value, and negative predictive value in diagnosing diabetic cardiomyopathy, with significant value in early diagnosis and lesion assessment.
References
[1] Amano Y, Suzuki Y, Iso K, et al. Diagnostic usefulness and limitation of cardiac magnetic resonance for identifying myocardial damage in survivors of cardiac arrest in midtown. World J Radiol. 2025;17:106-114.
[2] Li Y, Yin X, Cui S, et al. Study on the diagnostic efficacy of multimodal cardiovascular imaging in diabetic cardiomyopathy. J Hebei Med Univ. 2022;43:187-192.
[3] Pugliese L, Ricci F, Sica G, et al. Non-contrast and contrast-enhanced cardiac computed tomography imaging in the diagnostic and prognostic evaluation of coronary artery disease. Diagnostics (Basel). 2023;13:2074-2081.
[4] Xu J, Yang W, Zhao S, et al. State-of-the-art myocardial strain by CMR feature tracking: clinical applications and future perspectives. Eur Radiol. 2022;32:5424-5435.
[5] Xue H, Li Y, Chen W, et al. Expression and clinical significance of serum IP-10 and CXCR3 in patients with diabetic cardiomyopathy. Int J Immunol. 2025;48:447-453.
[6] Xie R, Xue K, Zhao Z, et al. Study on serum GSN levels and clinical diagnostic value in subclinical diabetic cardiomyopathy. Mod Lab Med J. 2023;38:83-88.
[7] Zheng Z, Li X, Xie Y. Changes in HbA1c, NT-proBNP, Hcy, SOD and TC levels and their clinical significance in patients with diabetic cardiomyopathy. Lab Med. 2023;38:282-286.
[8] Zhou L, Tang Y. Pathogenesis of diabetic cardiomyopathy and the effects of GLP-1 receptor agonists. Chin J Cardiol. 2023;51:440-442.
[9] Zhang Y, Xu H, Li J, et al. Clinical value of CTA combined with serum DKK3 and Sestrin2 in diagnosing ischemic cardiomyopathy. Chin J CT MRI. 2025;23:127-130.
[10] Zhao Y, Liang S. Comparative study of MRI and echocardiography in diagnosing dilated cardiomyopathy. Chin J Anat Clin Med. 2024;29:124-127.
How to cite this paper
Analysis of the Efficacy of Cardiac CT Imaging and Cardiac Magnetic Resonance in Diagnosing Diabetic Cardiomyopathy
How to cite this paper: Jieting Gao, Kejun Wang, Ling Sang. (2026) Analysis of the Efficacy of Cardiac CT Imaging and Cardiac Magnetic Resonance in Diagnosing Diabetic Cardiomyopathy. International Journal of Clinical and Experimental Medicine Research, 10(1), 15-18.
DOI: http://dx.doi.org/10.26855/ijcemr.2026.01.004